Indexing and Listing
ISSN (Online) : 2277 –4572

JPSI
 
 

About Us

The Journal of Pharmaceutical and Scientific Innovation (JPSI) is a peer reviewed open access freely available bimonthly online Journal of Moksha Publishing House. JPSI publishes research in all branches of pharmaceutical and other sciences.

All the manuscripts will be subjected to peer review process. Articles of high innovative quality will be considered for publication. Articles involved in the exciting process of discovery and dissemination of knowledge will be given priority. After the review, manuscripts will be returned for revision along with reviewer’s and/or editor’s comments (if any). Decision on article will be taken on the basis of comments from reviewers.

The articles may be submitted via online submission or through emails. Please check our website www.jpsionline.com for further details. Your contribution and active participation will be highly appreciated.

 

Open Access Statement

JPSI is official publication of Moksha publishing house which publish it as fully open access journal that means all articles are freely available to readers without any subscription or access fees.

Benefits of open access for authors include:

  •  Free access for all users worldwide
  • Authors retain copyright to their work without restrictions
  • Good scope for accessibility and readership

 

 Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Chief Editor
Journal of Pharmaceutical and Scientific Innovation (JPSI)
(An official publication of Moksha Publishing House)
Email: editorjpsi@gmail.com, editorjpsi@jpsionline.com
Website: www.jpsionline.com
 

 

 

Latest News & Conference

International Research Journal of Pharmacy included in UGC approved list of journals (Sr. No. 17846)

 

IJRAP is included in UGC approved List of Journals (Sr. No. 17498) Source: http://www.ugc.ac.in

 

Health ministry notifies Medical Devices Rules, 2017 which will come into force from January 1, 2018 (Source: Pharmabiz)

 

Zika: We must be ready for the long haul (Source: WHO)

 

Syncremedies launched

more
 

Ethics Committee Registration (Source: cdsco)

 

Clinical Trials Registry-India (CTRI) (Source: http://www.ctri.nic.in/)

 

CAREER OPPORTUNITY IN PHARMACOVIGILANCE

 

LIST OF DRUGS BANNED IN INDIA (Source:http://cdsco.nic.in/)

 

Drug Interactions Checker(Source:http://www.drugs.com)

 

Medical Product Safety Information(http://www.fda.gov)

more
 
 
Journal of Biological and Scientific Opinion